Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients.

Drusbosky LM, Singh NK, Hawkins KE, Salan C, Turcotte M, Wise EA, Meacham A, Vijay V, Anderson GG, Kim CC, Radhakrishnan S, Ullal Y, Talawdekar A, Sikora H, Nair P, Khanna-Gupta A, Abbasi T, Vali S, Guha S, Farhadfar N, Murthy HS, Horn BN, Leather HL, Castillo P, Tucker C, Cline C, Pettiford L, Lamba JK, Moreb JS, Brown RA, Norkin M, Hiemenz JW, Hsu JW, Slayton WB, Wingard JR, Cogle CR.

Blood Adv. 2019 Jun 25;3(12):1837-1847. doi: 10.1182/bloodadvances.2018028316.

2.

Poor peripheral blood stem cell mobilization affects long-term outcomes in multiple myeloma patients undergoing autologous stem cell transplantation.

Moreb JS, Byrne M, Shugarman I, Zou F, Xiong S, May WS, Norkin M, Hiemenz J, Brown R, Cogle C, Wingard JR, Hsu JW.

J Clin Apher. 2018 Feb;33(1):29-37. doi: 10.1002/jca.21556. Epub 2017 May 29.

PMID:
28556233
3.

Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections.

Hamadeh IS, Klinker KP, Borgert SJ, Richards AI, Li W, Mangal N, Hiemenz JW, Schmidt S, Langaee TY, Peloquin CA, Johnson JA, Cavallari LH.

Pharmacogenet Genomics. 2017 May;27(5):190-196. doi: 10.1097/FPC.0000000000000277.

4.

Effect of melphalan 140 mg/m(2) vs 200 mg/m(2) on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experience.

Katragadda L, McCullough LM, Dai Y, Hsu J, Byrne M, Hiemenz J, May S, Cogle CR, Norkin M, Brown RA, Wingard JR, Chang M, Moreb JS.

Clin Transplant. 2016 Aug;30(8):894-900. doi: 10.1111/ctr.12762. Epub 2016 Jun 29.

PMID:
27219740
5.

A new model to predict remission status in AML patients based on day 14 bone marrow biopsy.

Norkin M, Chang M, An Q, Leather H, Katragadda L, Li Y, Moreb JS, May WS, Brown RA, Hsu JW, Hiemenz JW, Wingard JR, Cogle CR.

Leuk Res. 2016 Jul;46:69-73. doi: 10.1016/j.leukres.2016.04.013. Epub 2016 Apr 20.

PMID:
27132034
6.

Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic stem cell transplantation.

Riwes MM, Leather H, Neal D, Bennett C, Sugrue M, Cline C, Stokes J, Hiemenz J, Hsu J, Wingard JR.

Bone Marrow Transplant. 2016 Sep;51(9):1228-32. doi: 10.1038/bmt.2016.92. Epub 2016 Apr 18.

PMID:
27088382
7.

Voriconazole therapeutic drug monitoring: results of a prematurely discontinued randomized multicenter trial.

Neofytos D, Ostrander D, Shoham S, Laverdiere M, Hiemenz J, Nguyen H, Clarke W, Brass L, Lu N, Marr KA.

Transpl Infect Dis. 2015 Dec;17(6):831-7. doi: 10.1111/tid.12454. Epub 2015 Nov 25.

8.

Aztreonam for febrile neutropenia in patients with beta-lactam allergy.

McCullough BJ, Wiggins LE, Richards A, Klinker K, Hiemenz JW, Wingard JR.

Transpl Infect Dis. 2014 Feb;16(1):145-52. doi: 10.1111/tid.12148. Epub 2013 Oct 14.

PMID:
24119095
9.

How I manage pulmonary nodular lesions and nodular infiltrates in patients with hematologic malignancies or undergoing hematopoietic cell transplantation.

Wingard JR, Hiemenz JW, Jantz MA.

Blood. 2012 Aug 30;120(9):1791-800. doi: 10.1182/blood-2012-02-378976. Epub 2012 Jun 12.

10.

Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology.

Wingard JR, Hsu J, Hiemenz JW.

Hematol Oncol Clin North Am. 2011 Feb;25(1):101-16. doi: 10.1016/j.hoc.2010.11.008.

PMID:
21236393
11.

Efficacy of caspofungin as salvage therapy for invasive aspergillosis compared to standard therapy in a historical cohort.

Hiemenz JW, Raad II, Maertens JA, Hachem RY, Saah AJ, Sable CA, Chodakewitz JA, Severino ME, Saddier P, Berman RS, Ryan DM, Dinubile MJ, Patterson TF, Denning DW, Walsh TJ.

Eur J Clin Microbiol Infect Dis. 2010 Nov;29(11):1387-94. doi: 10.1007/s10096-010-1013-0. Epub 2010 Aug 12.

PMID:
20703506
12.

Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology.

Wingard JR, Hsu J, Hiemenz JW.

Infect Dis Clin North Am. 2010 Jun;24(2):257-72. doi: 10.1016/j.idc.2010.01.010. Review.

PMID:
20466269
13.

Management of infections complicating allogeneic hematopoietic stem cell transplantation.

Hiemenz JW.

Semin Hematol. 2009 Jul;46(3):289-312. doi: 10.1053/j.seminhematol.2009.03.005. Review.

PMID:
19549581
14.

Population pharmacokinetics of micafungin in adult patients.

Gumbo T, Hiemenz J, Ma L, Keirns JJ, Buell DN, Drusano GL.

Diagn Microbiol Infect Dis. 2008 Mar;60(3):329-31. Epub 2007 Nov 19.

PMID:
18024052
15.

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary JD, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, dePauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano G, Ellis M, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, Hospenthal DR, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH, Knapp K, Kontoyiannis DP, Krcmery VC, Larsen R, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA, Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela JL, Rotstein C, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobel J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano A, Vartivarian S, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL, Zaoutis T.

Clin Infect Dis. 2006 Oct 15;43(8):1031-9. Epub 2006 Sep 13. No abstract available. Erratum in: Clin Infect Dis. 2007 Mar 15;44(6):894.

PMID:
16983616
16.

Hand and eye preference and their association with task approach by preschoolers.

Mahone EM, Wodka EL, Hiemenz JR.

Percept Mot Skills. 2006 Jun;102(3):691-702.

PMID:
16916148
17.

Gross and fine motor skills of children with Hurler syndrome (MPS-IH) post umbilical cord blood transplantation: a case series report.

Dusing SC, Rosenberg A, Hiemenz JR, Piner S, Escolar M.

Pediatr Phys Ther. 2005 Winter;17(4):264-7. Erratum in: Pediatr Phys Ther. 2006 Spring;18(1):48.

PMID:
16357681
19.

Construct validity of the auditory continuous performance test for preschoolers.

Mahone EM, Pillion JP, Hoffman J, Hiemenz JR, Denckla MB.

Dev Neuropsychol. 2005;27(1):11-33.

PMID:
15737941
20.

Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.

van Burik JA, Ratanatharathorn V, Stepan DE, Miller CB, Lipton JH, Vesole DH, Bunin N, Wall DA, Hiemenz JW, Satoi Y, Lee JM, Walsh TJ; National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Clin Infect Dis. 2004 Nov 15;39(10):1407-16. Epub 2004 Oct 27.

PMID:
15546073
21.

Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myeloma.

Ballester OF, Fang T, Raptis A, Ballester G, Wilcox P, Hiemenz J, Tan B.

Bone Marrow Transplant. 2004 Sep;34(5):419-23.

PMID:
15286696
22.

The relationship between perisylvian morphology and verbal short-term memory functioning in children with neurodevelopmental disorders.

Kibby MY, Kroese JM, Morgan AE, Hiemenz JR, Cohen MJ, Hynd GW.

Brain Lang. 2004 Apr;89(1):122-35.

PMID:
15010244
23.

Infections due to emerging and uncommon medically important fungal pathogens.

Walsh TJ, Groll A, Hiemenz J, Fleming R, Roilides E, Anaissie E.

Clin Microbiol Infect. 2004 Mar;10 Suppl 1:48-66. Review.

24.

Validity of the behavior rating inventory of executive function in children with ADHD and/or Tourette syndrome.

Mahone EM, Cirino PT, Cutting LE, Cerrone PM, Hagelthorn KM, Hiemenz JR, Singer HS, Denckla MB.

Arch Clin Neuropsychol. 2002 Oct;17(7):643-62.

PMID:
14591848
25.

Age and task parameters in continuous performance tests for preschoolers.

Hagelthorn KM, Hiemenz JR, Pillion JP, Mahone EM.

Percept Mot Skills. 2003 Jun;96(3 Pt 1):975-89.

PMID:
12831279
26.

Amphotericin B deoxycholate administered by continuous infusion: does the dosage make a difference?

Hiemenz JW.

Clin Infect Dis. 2003 Apr 15;36(8):952-3. Epub 2003 Apr 4. No abstract available.

PMID:
12684905
27.

The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

Perfect JR, Cox GM, Lee JY, Kauffman CA, de Repentigny L, Chapman SW, Morrison VA, Pappas P, Hiemenz JW, Stevens DA; Mycoses Study Group.

Clin Infect Dis. 2001 Dec 1;33(11):1824-33. Epub 2001 Oct 22.

PMID:
11692293
28.

Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses.

Rex JH, Walsh TJ, Nettleman M, Anaissie EJ, Bennett JE, Bow EJ, Carillo-Munoz AJ, Chavanet P, Cloud GA, Denning DW, de Pauw BE, Edwards JE Jr, Hiemenz JW, Kauffman CA, Lopez-Berestein G, Martino P, Sobel JD, Stevens DA, Sylvester R, Tollemar J, Viscoli C, Viviani MA, Wu T.

Clin Infect Dis. 2001 Jul 1;33(1):95-106. Epub 2001 Jun 5.

PMID:
11389501
29.

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group.

Patterson TF, Kirkpatrick WR, White M, Hiemenz JW, Wingard JR, Dupont B, Rinaldi MG, Stevens DA, Graybill JR.

Medicine (Baltimore). 2000 Jul;79(4):250-60.

30.
31.

Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis.

Wingard JR, Kubilis P, Lee L, Yee G, White M, Walshe L, Bowden R, Anaissie E, Hiemenz J, Lister J.

Clin Infect Dis. 1999 Dec;29(6):1402-7.

PMID:
10585786
32.

Amphotericin B lipid complex in pediatric patients with invasive fungal infections.

Walsh TJ, Seibel NL, Arndt C, Harris RE, Dinubile MJ, Reboli A, Hiemenz J, Chanock SJ.

Pediatr Infect Dis J. 1999 Aug;18(8):702-8.

PMID:
10462340
33.

A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.

Freifeld A, Marchigiani D, Walsh T, Chanock S, Lewis L, Hiemenz J, Hiemenz S, Hicks JE, Gill V, Steinberg SM, Pizzo PA.

N Engl J Med. 1999 Jul 29;341(5):305-11.

34.

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Walsh TJ, Finberg RW, Arndt C, Hiemenz J, Schwartz C, Bodensteiner D, Pappas P, Seibel N, Greenberg RN, Dummer S, Schuster M, Holcenberg JS.

N Engl J Med. 1999 Mar 11;340(10):764-71.

35.

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

Walsh TJ, Hiemenz JW, Seibel NL, Perfect JR, Horwith G, Lee L, Silber JL, DiNubile MJ, Reboli A, Bow E, Lister J, Anaissie EJ.

Clin Infect Dis. 1998 Jun;26(6):1383-96.

PMID:
9636868
36.

High-dose chemotherapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma and renal insufficiency.

Ballester OF, Tummala R, Janssen WE, Fields KK, Hiemenz JW, Goldstein SC, Perkins JB, Sullivan DM, Rosen R, Sackstein R, Zorsky P, Saez R, Elfenbein GJ.

Bone Marrow Transplant. 1997 Oct;20(8):653-6.

37.

Nephrotoxicity of high-dose ifosfamide/carboplatin/etoposide in adults undergoing autologous stem cell transplantation.

Agaliotis DP, Ballester OF, Mattox T, Hiemenz JW, Fields KK, Zorsky PE, Goldstein SC, Perkins JB, Rosen RM, Elfenbein GJ.

Am J Med Sci. 1997 Nov;314(5):292-8.

PMID:
9365330
38.

Nocardiosis after bone marrow transplantation: a retrospective study.

van Burik JA, Hackman RC, Nadeem SQ, Hiemenz JW, White MH, Flowers ME, Bowden RA.

Clin Infect Dis. 1997 Jun;24(6):1154-60.

PMID:
9195074
39.

Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis.

White MH, Anaissie EJ, Kusne S, Wingard JR, Hiemenz JW, Cantor A, Gurwith M, Du Mond C, Mamelok RD, Bowden RA.

Clin Infect Dis. 1997 Apr;24(4):635-42.

PMID:
9145737
40.

Dexamethasone, cyclophosphamide, idarubicin and etoposide (DC-IE): a novel, intensive induction chemotherapy regimen for patients with high-risk multiple myeloma.

Ballester OF, Moscinski LC, Fields KK, Hiemenz JW, Zorsky PE, Goldstein SC, Saba HI, Spiers AS, Kronish L, Sullivan P, Elfenbein GJ.

Br J Haematol. 1997 Mar;96(4):746-8.

PMID:
9074417
41.

Identification of an amphotericin B resistant strain of Candida albicans using a rapid 3H-glucose incorporation microassay.

Sweeney JF, Greene JN, Hiemenz JW, Wei S, Rosemurgy AS, Djeu JY.

J Infect. 1996 Nov;33(3):221-6.

PMID:
8945714
42.

Methylobacterium bacteremia after infusion of contaminated autologous bone marrow.

Brown MA, Greene JN, Sandin RL, Hiemenz JW, Sinnott JT.

Clin Infect Dis. 1996 Nov;23(5):1191-2. No abstract available.

PMID:
8922835
43.

Phase I-II study of high-dose busulfan and cyclophosphamide followed by autologous peripheral blood stem cell transplantation for hematological malignancies: toxicities and hematopoietic recovery.

Ballester OF, Agaliotis DP, Hiemenz JW, Janssen WE, Fields KK, Zorksy PE, Goldstein SC, Perkins JB, Elfenbein GJ.

Bone Marrow Transplant. 1996 Jul;18(1):9-14.

PMID:
8831989
44.

Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients.

Walsh TJ, Hiemenz JW, Anaissie E.

Infect Dis Clin North Am. 1996 Jun;10(2):365-400. Review.

PMID:
8803625
45.

Lipid formulations of amphotericin B: recent progress and future directions.

Hiemenz JW, Walsh TJ.

Clin Infect Dis. 1996 May;22 Suppl 2:S133-44. Review.

PMID:
8722841
46.

Maximum-tolerated doses of ifosfamide, carboplatin, and etoposide given over 6 days followed by autologous stem-cell rescue: toxicity profile.

Fields KK, Elfenbein GJ, Lazarus HM, Cooper BW, Perkins JB, Creger RJ, Ballester OF, Hiemenz JH, Janssen WE, Zorsky PE.

J Clin Oncol. 1995 Feb;13(2):323-32.

PMID:
7844593
47.

High-dose ifosfamide/carboplatin/etoposide: maximum tolerable doses, toxicities, and hematopoietic recovery after autologous stem cell reinfusion.

Fields KK, Elfenbein GJ, Perkins JB, Janssen WE, Ballester OF, Hiemenz JW, Zorsky PE, Kronish LE, Foody MC.

Semin Oncol. 1994 Oct;21(5 Suppl 12):86-92.

PMID:
7527592
48.

Prevention of Infection in Patients Undergoing Ablative Chemotherapy and Bone Marrow or Peripheral Blood Stem Cell Transplantation.

Hiemenz JW, Toney JF, Hiemenz SK, Greene JN.

Cancer Control. 1994 May;1(3):269-277. No abstract available.

PMID:
10886977
49.

Blood and Bone Marrow Hematopoietic Stem Cells for Transplantation: A Comparative Review.

Janssen WE, Hiemenz JW, Fields KK, Zorsky PE, Ballester OF, Goldstein SC, Elfenbein GJ.

Cancer Control. 1994 May;1(3):225-230.

PMID:
10886972
50.

High-dose Chemotherapy and the Treatment of Metastatic Breast Cancer: Selecting the Regimen and the Source of Stem Cells.

Fields KK, Agaliotis DP, Janssen WE, Perkins JB, Ballester OF, Hiemenz JW, Zorsky PE, Elfenbein GJ.

Cancer Control. 1994 May;1(3):213-218.

PMID:
10886970

Supplemental Content

Loading ...
Support Center